1023 related articles for article (PubMed ID: 32564693)
1. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Iaccarino G; Grassi G; Borghi C; Ferri C; Salvetti M; Volpe M;
Hypertension; 2020 Aug; 76(2):366-372. PubMed ID: 32564693
[TBL] [Abstract][Full Text] [Related]
2. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension.
Mancusi C; Grassi G; Borghi C; Carugo S; Fallo F; Ferri C; Giannattasio C; Grassi D; Letizia C; Minuz P; Muiesan ML; Perlini S; Pucci G; Rizzoni D; Salvetti M; Sarzani R; Sechi L; Veglio F; Volpe M; Iaccarino G;
J Hypertens; 2021 Feb; 39(2):376-380. PubMed ID: 33186327
[TBL] [Abstract][Full Text] [Related]
3. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
Majeed J; Ajmera P; Goyal RK
Diabetes Res Clin Pract; 2020 Sep; 167():108349. PubMed ID: 32712124
[TBL] [Abstract][Full Text] [Related]
4. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
6. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
[No Abstract] [Full Text] [Related]
7. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.
Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G
Mayo Clin Proc; 2020 Jun; 95(6):1222-1230. PubMed ID: 32376099
[TBL] [Abstract][Full Text] [Related]
8. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.
South AM; Brady TM; Flynn JT
Hypertension; 2020 Jul; 76(1):16-22. PubMed ID: 32367746
[TBL] [Abstract][Full Text] [Related]
9. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
10. Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection.
Salah HM; Calcaterra G; Mehta JL
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):503-507. PubMed ID: 32748634
[TBL] [Abstract][Full Text] [Related]
11. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
Vázquez-Cornejo E
Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
[TBL] [Abstract][Full Text] [Related]
12. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
13. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study.
Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K
Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236
[TBL] [Abstract][Full Text] [Related]
14. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.
Bravi F; Flacco ME; Carradori T; Volta CA; Cosenza G; De Togni A; Acuti Martellucci C; Parruti G; Mantovani L; Manzoli L
PLoS One; 2020; 15(6):e0235248. PubMed ID: 32579597
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
Dworakowska D; Grossman AB
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection.
Chodick G; Nutman A; Yiekutiel N; Shalev V
J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32406512
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
Reynolds HR; Adhikari S; Pulgarin C; Troxel AB; Iturrate E; Johnson SB; Hausvater A; Newman JD; Berger JS; Bangalore S; Katz SD; Fishman GI; Kunichoff D; Chen Y; Ogedegbe G; Hochman JS
N Engl J Med; 2020 Jun; 382(25):2441-2448. PubMed ID: 32356628
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
Iaccarino G; Grassi G; Borghi C; Carugo S; Fallo F; Ferri C; Giannattasio C; Grassi D; Letizia C; Mancusi C; Minuz P; Perlini S; Pucci G; Rizzoni D; Salvetti M; Sarzani R; Sechi L; Veglio F; Volpe M; Muiesan ML;
PLoS One; 2020; 15(10):e0237297. PubMed ID: 33022004
[TBL] [Abstract][Full Text] [Related]
19. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
Son M; Seo J; Yang S
Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
[TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.
Iaccarino G; Borghi C; Cicero AFG; Ferri C; Minuz P; Muiesan ML; Mulatero P; Mulè G; Pucci G; Salvetti M; Savoia C; Sechi LA; Volpe M; Grassi G
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):105-108. PubMed ID: 32266708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
